Menopause is Big Business. Your Health is Personal.
What the science says — and what it actually means for you
Something has changed.
Perhaps it was your sleep first. Maybe your body began to feel different even though the number on the scales had barely moved. Your energy became less predictable, concentrating seemed harder, or your appetite changed. Perhaps a routine blood test suddenly showed cholesterol or glucose heading in a direction you weren’t expecting.
Or perhaps there was no single moment you could identify. You simply reached a point where you thought:
I don’t feel quite like myself.
So you did what most of us do when something changes and we don’t understand it.
You went looking for an answer.
And that is where I want to begin, because the environment in which women now look for answers about menopause has changed almost as dramatically as the conversation about menopause itself.
You went looking for an answer. You found a marketplace.
For a long time, menopause was under-discussed, under-researched and, for many women, inadequately recognised in healthcare. Greater awareness is overdue. Women should be able to talk openly about hot flushes, sleep, cognition, mood, sexual health, body composition and the other changes they may experience through perimenopause, menopause and beyond.
But increased attention has brought something else with it: commercial attention.
In an observational analysis of 1,000 Instagram posts collected from 10 popular menopause-related hashtags, 66.1% promoted branded menopause supplements. Only 18.3% were authored by credentialed clinicians, while 45% of the 20 most frequently promoted supplements contained proprietary blends (Eubanks & Shvartsman, 2026). Importantly, this tells us about the content appearing in that particular Instagram sample — not the quality of every menopause product or every piece of menopause information online.
The shift extends beyond social media. Farina et al. (2026) analysed Google Trends data from 2005 to 2025 across Australia, the United States and United Kingdom. Their commercialisation index — comparing menopause-related commercial search interest with commercial plus informational search interest — increased in Australia from 0.14 in 2010 to 0.33 in 2025. The authors appropriately caution that Google Trends measures relative search interest; it does not tell us what women ultimately bought, what happened clinically, or whether the information encountered was good or bad.
Australian women themselves have noticed the commercial environment. Wood et al. (2025) surveyed 509 Australian women aged 45–64 and identified concerns about commercial actors catastrophising menopause, capitalising on concerns about ageing and promoting products to women looking for relief. But the study also illustrates why the environment is more complicated than simply labelling women gullible: accessibility, lived experience and the perception of being listened to can all influence why commercial propositions appeal (Wood et al., 2025).
That distinction matters.
A woman who doesn’t feel right may not be shopping for a supplement, hormone panel, diet or menopause program.
She may simply be looking for an explanation.
Yet explanations can very quickly become propositions.
I came to menopause from a different direction. Its physiology formed part of my health-science training. But when I looked beyond the curriculum at how that physiology was being communicated to women, I found the marketplace too.
And I recognised some of what I was seeing.
Before studying Clinical Nutrition, I completed a degree in Marketing. Marketing taught me how a problem is identified and framed, how attention is captured and how a product or service is positioned as the bridge between where somebody is now and where they want to be.
At its simplest:
Problem → explanation → product → solution.
Menopause provides unusually fertile ground for that sequence because the underlying change is real. Physiology really is changing. Symptoms can be disruptive. Women have not always felt adequately heard. And there can be genuine uncertainty about what those changes mean for an individual woman.
Into that uncertainty can come some remarkably confident explanations.
Your cortisol is too high. Your hormones need balancing. Your gut isn’t clearing oestrogen. Your metabolism has crashed. You need magnesium. You need more protein. You need a hormone test. You shouldn’t fast. You absolutely should fast.
Some of those statements contain fragments of legitimate physiology. Some interventions may have a legitimate place in the right circumstances. And the fact that somebody sells something does not automatically make their explanation wrong.
But neither does a persuasive physiological explanation establish that their solution is what you need.
So before we go any further, there is one question worth keeping in mind:
Have you just become the product?
From marketing claims back to science
One of the difficulties with nutrition and menopause information is that almost anyone can find a study.
That isn’t the same as understanding the evidence.
Was the research observational, or did researchers actually intervene? Who was studied? Was it conducted in perimenopausal women, postmenopausal women, men, mice or cells in a laboratory? Was the effect meaningful or merely statistically detectable? Has the finding been replicated? Does it agree with the broader evidence? Who funded it? And does the conclusion being presented to you actually resemble what the researchers found?
Those are questions you should be able to ask of me too.
It’s part of why I use the phrase Navigate the Noise.
I use the same approach in the supermarket. You wouldn’t judge a novel by its cover. Yet every day we’re asked to judge our food by the front of the packet: high protein, gut health, natural, no added sugar, superfood.
Marketing taught me to understand why those words are there.
Clinical Nutrition taught me to turn the packet around and ask:
What are we actually getting?
Healthcare deserves at least the same scrutiny. A supplement can be marketed. A test can be marketed. A practitioner can be marketed. Even terms such as personalised, functional, root cause, hormone balancing and evidence-based can become part of a proposition.
The alternative isn’t cynicism.
It’s to reverse the sequence.
Don’t start with the solution. Start with what is actually changing.
And menopause really does change things.
What actually changes?
Menopause is often spoken about as though the ovaries gradually turn down a hormonal dial until menstruation stops.
Human physiology is considerably messier.
Ovarian function becomes increasingly variable through the transition. Oestradiol does not simply decline in a neat straight line, and women can follow different hormonal trajectories. Progesterone exposure changes as ovulation becomes less consistent, while communication between the ovaries, brain and other physiological systems is shifting at the same time.
That variability helps explain why the experience can differ so much between women. It also helps explain why, in otherwise healthy people aged 45 or older with typical menopause-associated symptoms, current guidance supports diagnosis from clinical history rather than routine confirmatory hormone testing. The UK's National Institute for Health and Care Excellence (NICE) specifically notes that hormone concentrations fluctuate during perimenopause and generally do not add diagnostic value in this setting (NICE, 2024).
More importantly, these hormones do considerably more than regulate reproduction. Longitudinal evidence has linked the menopause transition with changes in body composition, lipids and lipoproteins, vascular health and bone, while sleep, thermoregulation and cognitive symptoms can also become clinically important (El Khoudary et al., 2020).
But there is another process occurring simultaneously.
Ageing.
And around both sit physical activity, nutrition, sleep, alcohol, medications, illness, work, caring responsibilities and the metabolic health a woman brings into these years.
The interesting clinical question therefore isn’t whether menopause matters.
It does.
The question is where menopause sits within everything else that is happening to you.
If several things seem to have changed and you genuinely don’t know which one to deal with first, that’s also why I built the free Menopause Start Here tool. It doesn’t diagnose menopause or give you a score. It helps you begin organising the picture.
Did your weight change — or did your body change?
“Menopause weight gain” has become such a familiar phrase that it can sound almost inevitable.
The longitudinal evidence tells a more interesting story.
In the Study of Women’s Health Across the Nation (SWAN), researchers repeatedly measured women’s body composition as they moved through the menopause transition. The rate of weight gain did not suddenly accelerate with the transition. What did change around the final menstrual period were the trajectories of fat and lean tissue: fat gain approximately doubled while lean mass shifted from gain to loss. These changes were relatively modest in absolute terms but help explain why body composition can change without a dramatic change on the scales (Greendale et al., 2019).
Other longitudinal evidence has identified adverse changes in body-fat distribution through midlife and menopause, including greater central adiposity, although chronological ageing and menopause cannot always be cleanly separated (El Khoudary et al., 2020).
That distinction matters.
Two women can weigh exactly the same as they did several years ago while having a different proportion of fat and lean tissue and a different distribution of body fat. Conversely, a woman gaining weight in her forties or fifties should not automatically be told that oestrogen is responsible for every kilogram.
Chronological ageing, physical activity, sleep, dietary intake, alcohol, medications and previous weight trajectory still matter.
So if your body has changed, think about the chronology for a moment.
When did you first notice it, and what else had changed around the same time?
Had sleep deteriorated? Were you moving differently? Had your strength changed? Was appetite different? Had alcohol become more frequent? Had work, caring responsibilities or medication changed?
Those details don’t make menopause irrelevant.
They help us understand where it may sit within the picture.
And they bring us to something that gets less attention than the scales.
Muscle matters — and not just because of how it looks
Skeletal muscle is metabolically active tissue. It supports strength and physical independence and provides an important site for glucose disposal, while mechanical loading also contributes to skeletal health.
The menopause transition may contribute to changes in lean tissue, but the relationship between ovarian hormones and skeletal muscle is more complicated than the popular claim that declining oestrogen simply causes muscle to disappear.
What is much clearer is that muscle remains responsive to being used. A 2024 systematic review and meta-analysis of randomised trials in healthy postmenopausal women found resistance training improved measures of upper- and lower-body strength, although effects on bone density and body-composition outcomes were less consistent (González-Gálvez et al., 2024).
Protein matters too: adequate dietary protein provides the amino acids required for muscle protein synthesis. But protein isn’t muscle preservation by itself. A systematic review and meta-analysis of whey protein supplementation in postmenopausal women found benefits to muscle strength and lean mass when supplementation was combined with resistance training, while whey protein without resistance training did not significantly improve strength or lean mass (Kuo et al., 2022).
Protein gives muscle something to work with. Resistance gives it a reason to stay.
That doesn’t necessarily mean finding another hour in a week that already feels full. A structured strength program can be valuable, but the starting point for one person may simply be making resistance a more regular feature of life.
Research into brief “exercise snacks” is developing. A 2026 systematic review and meta-analysis found improvements in cardiorespiratory fitness in physically inactive adults and some evidence for muscular endurance in older adults, with high adherence. It did not, however, find significant improvements in lower-limb strength, body composition or the cardiometabolic outcomes examined (Rodríguez et al., 2026).
So exercise snacks may be a practical way of getting more movement into real life. They shouldn’t yet be sold as a miniature replacement for everything conventional resistance training can achieve.
The practical question isn’t simply “Do you exercise?”
How much resistance are your muscles encountering now compared with five years ago? How much protein are you actually eating? How is it distributed through your day? And if either has changed, what got in the way — time, pain, confidence, appetite, injury, caring responsibilities or simply a routine that stopped fitting your life?
If protein is one of the things you’re wondering about, the free Protein Target Calculator can give you a starting point to explore.
What happened to your metabolic health?
This is another area where menopause can easily become an all-purpose explanation.
The transition is associated with changes in cardiovascular and metabolic risk, but not every marker follows the same trajectory. Longitudinal research has identified menopause-related changes particularly in body composition, lipids and lipoproteins and measures of vascular health. Glucose regulation, blood pressure and other cardiometabolic measures are also strongly influenced by chronological ageing, body composition, activity, sleep and pre-existing risk (El Khoudary et al., 2020).
That is clinically important.
If HbA1c has risen, blood pressure has changed or cholesterol has increased, “it’s menopause” isn’t an adequate assessment.
Neither is “it’s your lifestyle.”
Were those markers already moving before your periods began changing, or did their trajectory alter later?
A laboratory result is a moment in time. Previous results, family history, body-composition changes, activity, medications and what has happened across several years give it context.
This is also why preserving muscle, supporting dietary quality, moving regularly, sleeping adequately and understanding alcohol intake aren’t simply strategies for navigating symptoms. They are part of a broader metabolic-health picture that matters during these years and for the decades that follow.
Sleep isn’t time when nothing is happening
Sleep disturbance is common through the menopause transition, but “menopause sleep” isn’t one condition.
For one woman, vasomotor symptoms may repeatedly wake her. Another may develop persistent insomnia. Another may struggle with mental activation at bedtime. And another may have sleep-disordered breathing or obstructive sleep apnoea.
Those distinctions matter because the appropriate response is different.
Menopausal hormone therapy can be an evidence-based medical treatment for appropriate women and is particularly effective for vasomotor symptoms. Evidence from randomised trials suggests MHT can also improve subjective sleep, particularly where vasomotor symptoms are present; it should not be treated as a universal treatment for every form of sleep disturbance (Cintron et al., 2017).
Whether MHT is appropriate is an individual medical decision to make with a GP or appropriately qualified medical practitioner.
Nutrition is not an alternative ideology to appropriate menopause care. My role sits alongside medical care, not in competition with it.
Sleep also has consequences beyond feeling tired the following morning.
A 2023 randomised crossover experiment specifically studied postmenopausal women. Fourteen women completed the sleep conditions and nine were included in the analysis. Four nights of restricted sleep reduced insulin sensitivity compared with habitual sleep (Singh et al., 2023).
That is a small, short-term experimental study. It does not establish that menopause causes insulin resistance, nor that every woman experiencing disturbed sleep will experience the same metabolic response.
It does give us another biological reason not to dismiss persistent insufficient sleep as merely an inconvenience.
A larger randomised trial in women has subsequently also found that chronic insufficient sleep impaired insulin sensitivity, with the adverse effect more pronounced among postmenopausal participants (Zuraikat et al., 2024).
A hot flush may wake you.
Repeatedly disrupted sleep can then begin exerting effects of its own.
So which came first? Did your sleep deteriorate before the fatigue, appetite or body-composition changes, or afterwards? Are you waking hot, lying awake unable to switch off, snoring, waking repeatedly, or simply not giving yourself enough opportunity to sleep?
Those are different problems hiding beneath the same sentence:
“I’m not sleeping.”
The free Sleep Reality Check is designed around that distinction. It helps you look at where the pressure may be coming from rather than assuming every sleep problem has the same cause.
“My brain just doesn’t work the way it used to.”
Brain fog is real as an experience.
But we need to be careful about what that means scientifically.
Women commonly report changes in memory, word retrieval, attention and mental clarity during the menopause transition. A 2025 systematic review and meta-analysis involving 5,629 participants found only a small association between subjective cognitive complaints and objective measures of learning efficiency, with correlations across several other cognitive domains not statistically significant (Furey et al., 2025).
In other words, how cognitively different somebody feels and what a formal neuropsychological test detects are related only imperfectly.
Landmark longitudinal SWAN research adds another important piece. Across 2,362 women followed for four years, some perimenopausal stages were associated with a failure to show the usual improvement that occurs when cognitive tests are repeated, rather than demonstrating a simple progressive decline in cognitive ability (Greendale et al., 2009).
That is not the same as saying menopause causes dementia.
Nor does every forgotten word demonstrate oestrogen deficiency.
Sleep, mood, vasomotor symptoms, medications and the cognitive load of life can all be part of the picture.
So again, chronology can be useful.
Did the brain fog arrive alongside disrupted sleep and hot flushes, or does it have a different timeline?
The answer may not fit neatly into a menopause headline.
That’s precisely why it’s worth asking.
Bone changes whether you can feel it or not
Bone is different from many other menopause-related changes because substantial change can occur without producing a symptom.
Longitudinal SWAN data demonstrate that bone loss accelerates around the late menopause transition and early postmenopause, although the rate and magnitude vary between women (Finkelstein et al., 2008).
Nutrition matters here, including adequate calcium, vitamin D and protein. But reducing the conversation to supplements misses part of the physiology.
Bone responds to loading.
Resistance and appropriate weight-bearing or impact exercise therefore sit alongside nutrition, assessment of individual fracture risk and medical management where indicated.
Vitamin D matters too, particularly where deficiency or insufficiency exists. But the fact that vitamin D is physiologically important doesn’t establish that every woman going through menopause needs a bottle of it.
If you’re wondering about your own vitamin D context, my free Vitamin D Reality Check looks at some of the factors relevant to vitamin D rather than beginning with a supplement.
The broader principle is worth keeping:
A nutrient being important does not establish that more of it is always better.
What about supplements?
Supplements can have a legitimate place in clinical care.
But this isn’t where I give you my menopause supplement stack.
That would rather undermine everything we’ve been discussing.
“Magnesium”, “creatine”, “omega-3” or “menopause support” on the front of a bottle doesn’t tell us whether that particular product is appropriate for you. Products can differ in dose, chemical form, combination ingredients and excipients. Suitability can also depend on medications, health history, dietary intake, pathology, gastrointestinal tolerance, kidney function and — most importantly — what we are actually trying to achieve.
So the clinical question should come before the bottle.
What are we trying to change? Is there evidence this is likely to help? Is this particular product appropriate for you? And how will we know whether it actually did anything meaningful?
Sometimes supplementation is appropriate.
Sometimes it isn’t.
And sometimes assessment saves you money by establishing that you don’t need to buy another product at all.
Fibre matters. The “estrobolome” is a different question.
There are very good reasons to care about fibre through midlife.
Fibre supports bowel function and contributes to cardiometabolic health, satiety and dietary quality. Fibre-rich eating patterns also tend to bring legumes, whole grains, vegetables, fruit, nuts and seeds — foods with health implications extending well beyond menopause.
There is also legitimate scientific interest in interactions between the gut microbiome and oestrogen metabolism. Bacterial enzymes can participate in deconjugation and enterohepatic recycling of oestrogens.
That is real biology.
What is much less established is the commercial leap from that biology to:
Your estrobolome is broken → your oestrogen isn’t detoxifying → therefore you need this test, probiotic or protocol.
A 2026 narrative review in Menopause describes the evidence linking estradiol, menopause and the gut microbiome as emerging. Much of the human evidence remains observational and important questions about causality and therapeutic application remain unresolved (Palacios et al., 2026).
Mechanism is not the same as demonstrated clinical utility.
So I don’t need to diagnose your “estrobolome” to have a very good reason to ask how much fibre you are eating.
Sometimes the less exotic intervention has the stronger evidence.
And “eat more fibre” isn’t particularly useful if you don’t know what that looks like across an actual day. That’s what the free Fibre Planner is designed to help with.
And then there’s alcohol
Alcohol deserves a more serious conversation than either “a glass of red wine is good for your heart” or “never drink again.”
The evidence isn’t equally strong for every claim made about it.
Alcohol is an established cause of cancer, including breast cancer, and risk increases with consumption (Cancer Council Australia, 2026). Australian guidance therefore frames alcohol around reducing health risk rather than recommending a cardioprotective dose (National Health and Medical Research Council, 2020).
Its relationship with individual menopausal symptoms such as hot flushes is less straightforward than some menopause advice suggests.
Sleep is another consideration. Alcohol can affect sleep across the night. It also provides energy without necessarily producing equivalent satiety, making it relevant when we’re trying to understand appetite, energy intake and body composition.
The useful clinical question therefore isn’t:
“Is alcohol allowed during menopause?”
It is what alcohol is doing in your particular picture.
How much? How often? When? What happens to sleep afterwards? Does it alter appetite or food choices? Is it contributing meaningfully to energy intake? What does it mean in the context of breast-cancer risk and your broader medical history?
Population guidance gives us a risk framework.
Individual assessment gives that information context.
Before fasting, I want to talk about rhythm
Nutrition conversations tend to focus overwhelmingly on what we eat. Human physiology also pays attention to when things happen.
Our central circadian clock is strongly entrained by the light-dark cycle, while metabolic tissues throughout the body also display circadian rhythms. Sleep and wake timing, physical activity and food intake provide additional signals that interact with those systems.
That makes meal timing scientifically interesting.
It does not establish one ideal eating window for every woman.
And this is an area where the menopause-specific intervention evidence remains limited.
A particularly useful recent example comes from Peters et al. (2025). In a controlled study of 31 women with overweight — 26 of whom were postmenopausal — researchers compared early and late eight-hour time-restricted eating while attempting to keep energy intake unchanged. Adherence was high. Meal timing shifted circadian clocks, but neither eating window produced measurable improvements in the cardiometabolic outcomes assessed.
That does not establish that meal timing never matters.
It does show why interesting circadian physiology should not be converted automatically into a universal fasting prescription.
Eat breakfast.
Skip breakfast.
Never eat after 6 pm.
Fast for 16 hours.
Women shouldn’t fast.
Women should fast differently according to their hormones.
This is why I tend to talk about rhythm before I talk about fasting.
What time do you usually start eating? When does the kitchen actually close? Is dinner at 7 pm followed by grazing until 10.30? Does skipping breakfast improve your day, or simply leave you ravenous later? Is your eating pattern reasonably consistent, or does it swing dramatically depending on what life throws at you?
And perhaps more usefully:
What does an ordinary Tuesday actually look like?
Not the day when everything goes according to plan. The day when the meeting runs late, somebody needs picking up, you haven’t thought about dinner and the food environment suddenly becomes whatever is quickest.
A nutrition strategy that only works on your most organised day isn’t much of a strategy.
For some people, creating a more consistent overnight period without food may be useful. For another woman, a longer fasting window may make it harder to eat enough protein, worsen later hunger, interfere with medication or training, or simply add another rule to an already overloaded day.
Fasting is therefore one tool I may use within a bigger conversation about rhythm.
The question isn’t whether fasting is good or bad.
It’s what problem are we trying to solve, and does this tool help solve it?
I’ve written separately about why I chose to learn the Fast Like a Girl framework. Understanding a framework doesn’t mean accepting every claim within it; it allows me to examine where its ideas align with evidence, where they don’t, and whether any part is useful in an individual clinical context.
[WHY I LEARNED TO FAST LIKE A GIRL →]
What about the really basic things?
There is a risk in talking about hormones, microbiomes and circadian biology that ordinary foundations begin to sound unsophisticated.
They aren’t.
Hydration is a good example. It doesn’t need to be reframed as a menopause treatment to matter to normal physiology and everyday wellbeing. Nor does everyone need to carry around an enormous bottle and chase an arbitrary internet target.
If you’re unsure what Australian guidance looks like in practical terms, the free Hydration Calculator gives you a simple place to start.
These tools are designed to help you explore one part of your own picture. They don’t diagnose menopause, replace individual assessment or tell you what treatment you need.
So what do you need?
Notice what I haven’t done.
I haven’t told you that you need a supplement stack.
I haven’t prescribed you a protein target.
I haven’t told you to fast.
I haven’t told you to stop drinking alcohol.
I haven’t decided that your brain fog is caused by menopause, that your changing waist is caused entirely by oestrogen, or that a hormone panel will reveal the answer.
That is deliberate.
Assessment isn’t guessing. But neither is it ordering every available test or selecting an intervention before we’ve established what question we’re trying to answer.
Contemporary menopause guidance takes essentially this assessment-first approach: establish why somebody has presented, consider the clinical context and individual circumstances, and then determine what assessment and management are appropriate (Davis et al., 2023; NICE, 2024).
Good clinical care starts with why somebody has presented, what has changed, when it changed, what else was happening, relevant medical history and pathology, medications, nutrition, sleep, activity, risk factors and what has already been tried.
Sometimes that assessment points towards nutrition.
Sometimes it identifies a meaningful reason for further investigation or testing.
Sometimes it points back to your GP or another health professional.
And sometimes several things need to happen together.
Testing should answer a clinical question, not create a sales funnel.
That’s a subject worth exploring properly in another article.
Where Clinical Nutrition fits
I can’t change menopause. And I don’t need to pretend I can.
I’m not positioning myself as a women’s-health or fertility practitioner, and there are important aspects of menopause that sit outside my scope. But menopause doesn’t occur in isolation from the rest of your physiology.
The hormonal changes of the transition interact with ageing, body composition, sleep, physical activity, nutrition and the metabolic health you bring into these years. Together, those factors influence systems that are fundamental to health: skeletal muscle and strength, glucose and lipid metabolism, bone, appetite and satiety, energy, sleep and how well you feel and function day to day.
That intersection is very much my lane.
In practice, that might mean looking at your dietary pattern, protein and fibre intake, alcohol, sleep opportunity, resistance activity, medications and supplements, relevant pathology and how those pieces have changed over time.
Clinical Nutrition gives us opportunities to work on those foundations. Not by promising to “balance your hormones”, reverse menopause or explain every symptom through oestrogen, but by working out which modifiable factors may be contributing to what brought you here and where nutrition, strength, sleep, eating rhythm and metabolic health can reasonably make a difference.
Sometimes that may help with symptoms. Sometimes the change we’re looking for is steadier energy, better satiety, improved metabolic markers, greater strength or a way of eating that actually works within your life.
And sometimes what we uncover tells us that nutrition isn’t the answer, or isn’t the whole answer, and another health professional needs to be part of the conversation.
There is a longer view too.
Menopause is a transition, not the destination.
The muscle, bone, cardiovascular and metabolic foundations we support through these years matter beyond the menopause transition itself. My interest therefore isn’t simply in helping you get through menopause. It’s in supporting how you feel and function now while building foundations for the quality of health and ageing you want in the decades beyond it.
Why professional accountability matters
This is also where I think the letters and accreditations attached to somebody’s name should mean something.
Accreditation doesn’t mean a practitioner will always be right. It should mean there are external professional expectations around evidence, competence, scope of practice, continuing professional development and knowing when referral is appropriate.
As a Certified Practicing Nutritionist, the Code of Conduct of the Australasian Association and Register of Practicing Nutritionists (AARPN) requires me to work within the limits of my competence and scope of practice, refer appropriately to other health professionals, undertake continuing professional development, and apply evidence-informed practice while recognising the need for continual critical evaluation of nutrition science (AARPN, 2024).
My professional registration is therefore not simply a badge to put underneath my name. It is part of the framework within which I practise.
And I think it’s reasonable to ask anyone giving you health advice:
What standards are they accountable to?
If you’ve spent enough time scrolling through people who already seem to know what you need before they’ve met you, let’s do it differently.
Let’s explore YOU
Population research can tell us what tends to happen through menopause.
It cannot tell me, from this webpage, what has happened to you.
That’s where chronology becomes useful.
If we were sitting together, I wouldn’t begin by reaching for a protocol. I’d want to hear the story behind what brought you here.
When did you first notice that something had changed?
What happened next — did it resolve, continue, become more frequent, or did something else begin changing as well?
What have you already tried, and what happened when you tried it?
Three questions don’t constitute an assessment.
But they begin turning a collection of symptoms, test results and concerns into a timeline.
And a timeline gives us somewhere to start.
You bring how it feels. I’ll bring the physiology. Then we’ll join the dots together.
Ready to continue the conversation?
If you would like to explore your individual situation, we can talk for 15 minutes, free, by video from the privacy of your own home.
Tell me what’s occupying your thoughts. I’ll listen, ask a few questions and we can work out whether Clinical Nutrition is an appropriate next step.
[BOOK A FREE 15-MINUTE DISCOVERY CALL]
Not ready to talk yet?
That’s fine.
You can continue exploring for yourself with the free Menopause Start Here, Protein, Fibre, Sleep, Vitamin D and Hydration tools.
Just want to follow along for a while?
You can do that too.
I publish Real Life Nutrition with Jon, where I navigate nutrition claims, supermarket marketing and the science behind what we’re being told to eat, buy and believe.
You don’t need to decide what you think about me today.
[SUBSCRIBE & NAVIGATE THE NOISE]
Going back to scrolling?
Take the filter with you.
I’ve put these questions into a simple Menopause Claim Check you can keep on your phone.
The next time you see a menopause claim, supplement, test or program that sounds convincing, open it and work through the questions before you decide.
[NAVIGATE THE MENOPAUSE NOISE →]
No score. No diagnosis. No predetermined answer.
Just better questions.
Whichever path you choose, you remain the person making the decision.
You came here looking for an answer. I hope I’ve given you some. But I’d rather you leave with better questions too.
What does the science say?
What does it actually mean?
Does it apply to me?
Population research can tell us what tends to happen. It cannot tell me, from a webpage, what has happened to you.
That’s where a conversation can begin.
The science matters. And so do you.
References & further reading
This isn’t intended to be an exhaustive menopause bibliography. These are the papers, guidelines and professional resources most relevant to the claims made in this article. I’ve included a short note with each because a citation is more useful when you know why it is here — and, sometimes, what it doesn’t establish.
Australasian Association and Register of Practicing Nutritionists. (2024). Code of conduct part 1: Practice guidelines for certified practicing nutritionists (Rev. October 2024). https://aarpn.com/wp-content/uploads/2025/05/AARPN-CPN-COC_Part-1_Practice-Guidelines_October-2024_VN.pdf
Why it matters: This is the primary professional source behind the accountability section. Part 1 requires Certified Practicing Nutritionists to recognise and work within the limits of their competence and scope of practice, refer appropriately to other allied health and medical professionals, maintain continuing professional development, and demonstrate evidence-informed application of scientific principles while recognising the need for continual critical evaluation of nutrition science.
Cancer Council Australia. (2026, August 7). Limit alcohol. https://www.cancer.org.au/cancer-information/causes-and-prevention/diet-and-exercise/limit-alcohol
Why it matters: Carries the cancer statement in this article on Australian authority: alcohol increases the risk of several cancers including breast cancer, even small amounts increase risk, and the risk rises with the amount consumed. It is a cancer position, not a cardiovascular one — those are two different questions with two different bodies of evidence.
Cintron, D., Lipford, M., Larrea-Mantilla, L., Spencer-Bonilla, G., Lloyd, R., Gionfriddo, M. R., Gunjal, S., Farrell, A. M., Miller, V. M., & Murad, M. H. (2017). Efficacy of menopausal hormone therapy on sleep quality: Systematic review and meta-analysis. Endocrine, 55(3), 702–711. https://doi.org/10.1007/s12020-016-1072-9
Why it matters: This review found the clearest sleep benefit from MHT in women who also had vasomotor symptoms. That is why this article does not treat every menopause-associated sleep problem as the same condition.
Davis, S. R., Taylor, S., Hemachandra, C., Magraith, K., Ebeling, P. R., Jane, F., & Islam, R. M. (2023). The 2023 practitioner's toolkit for managing menopause. Climacteric, 26(6), 517–536. https://doi.org/10.1080/13697137.2023.2258783
Why it matters: Provides a structured clinical framework for assessing and managing menopause and supports the individualised, assessment-first approach used throughout this article.
El Khoudary, S. R., Aggarwal, B., Beckie, T. M., Hodis, H. N., Johnson, A. E., Langer, R. D., Limacher, M. C., Manson, J. E., Stefanick, M. L., & Allison, M. A. (2020). Menopause transition and cardiovascular disease risk: Implications for timing of early prevention: A scientific statement from the American Heart Association. Circulation, 142(25), e506–e532. https://doi.org/10.1161/CIR.0000000000000912
Why it matters: One of the key evidence syntheses for distinguishing menopause-associated changes from chronological ageing. It supports the discussion of body composition, lipids, vascular health and longer-term cardiometabolic risk — while also supporting the restraint against claiming that menopause itself simply “causes insulin resistance.”
Eubanks, A. A., & Shvartsman, K. (2026). Social media and supplements for menopausal symptoms: A content analysis. BJOG: An International Journal of Obstetrics & Gynaecology. Advance online publication. https://doi.org/10.1111/1471-0528.70242
Why it matters: This is the source of the 1,000-post, 66.1%, 18.3% and 45% figures in the opening. It describes one Instagram sample; it does not establish that every menopause supplement or every piece of commercial menopause content is ineffective.
Farina, F. R., Griffith, J. W., Faubion, S. S., Hickey, M., Lensen, S., & Christmas, M. (2026). Online menopause information–seeking search patterns and commercial content over 2 decades. JAMA Network Open, 9(6), e2616596. https://doi.org/10.1001/jamanetworkopen.2026.16596
Why it matters: This is the source of the Australian commercialisation index increasing from 0.14 in 2010 to 0.33 in 2025. Importantly, the index measures the relative composition of commercial and informational search interest. It is not evidence that literally one-third of all menopause searches were commercial.
Finkelstein, J. S., Brockwell, S. E., Mehta, V., Greendale, G. A., Sowers, M. R., Ettinger, B., Lo, J. C., Johnston, J. M., Cauley, J. A., Danielson, M. E., & Neer, R. M. (2008). Bone mineral density changes during the menopause transition in a multiethnic cohort of women. The Journal of Clinical Endocrinology & Metabolism, 93(3), 861–868. https://doi.org/10.1210/jc.2007-1876
Why it matters: A landmark SWAN analysis showing that bone loss is not evenly distributed across midlife; it accelerates around the late menopause transition and early postmenopause.
Furey, R. T., Thomas, E. H. X., Kulkarni, J., & Gurvich, C. (2025). Subjective versus objective cognition during menopause: A systematic review and meta-analysis. Journal of the International Neuropsychological Society, 31(5–6), 459–477. https://doi.org/10.1017/S1355617725101306
Why it matters: Across 24 studies involving 5,629 participants, subjective cognitive complaints correlated only weakly with objective learning performance and did not map consistently onto several other objectively measured cognitive domains. It supports taking “brain fog” seriously without automatically interpreting it as measurable cognitive decline.
González-Gálvez, N., Moreno-Torres, J. M., & Vaquero-Cristóbal, R. (2024). Resistance training effects on healthy postmenopausal women: A systematic review with meta-analysis. Climacteric, 27(3), 296–304. https://doi.org/10.1080/13697137.2024.2310521
Why it matters: Supports resistance training for improving strength in postmenopausal women while showing why it would be too simplistic to promise identical effects across bone and body-composition outcomes.
Greendale, G. A., Huang, M.-H., Wight, R. G., Seeman, T., Luetters, C., Avis, N. E., Johnston, J., & Karlamangla, A. S. (2009). Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology, 72(21), 1850–1857. https://doi.org/10.1212/WNL.0b013e3181a71193
Why it matters: This SWAN study is behind the nuanced cognition discussion. Some perimenopausal women failed to demonstrate the usual practice effect on repeated testing. That is different from showing straightforward progressive cognitive decline.
Greendale, G. A., Sternfeld, B., Huang, M., Han, W., Karvonen-Gutierrez, C., Ruppert, K., Cauley, J. A., Finkelstein, J. S., Jiang, S.-F., & Karlamangla, A. S. (2019). Changes in body composition and weight during the menopause transition. JCI Insight, 4(5), e124865. https://doi.org/10.1172/jci.insight.124865
Why it matters: One of the most important papers for the weight discussion. SWAN data showed that total weight gain did not suddenly accelerate at menopause while the trajectories of fat and lean mass changed around the final menstrual period.
Kuo, Y.-Y., Chang, H.-Y., Huang, Y.-C., & Liu, C.-W. (2022). Effect of whey protein supplementation in postmenopausal women: A systematic review and meta-analysis. Nutrients, 14(19), 4210. https://doi.org/10.3390/nu14194210
Why it matters: Particularly useful for separating “protein is important” from “protein supplements preserve muscle.” In the analysis, whey protein without resistance training did not significantly improve muscle strength or lean mass; benefits were observed when protein supplementation was combined with resistance training.
National Health and Medical Research Council. (2020). Australian guidelines to reduce health risks from drinking alcohol. https://www.nhmrc.gov.au/about-us/publications/australian-guidelines-reduce-health-risks-drinking-alcohol
Why it matters: Provides the Australian risk framework for alcohol. The guidelines are designed around reducing alcohol-related disease and injury rather than prescribing alcohol for health benefit.
National Institute for Health and Care Excellence. (2024). Menopause: Identification and management (NICE Guideline No. NG23). https://www.nice.org.uk/guidance/ng23
Why it matters: Supports diagnosing typical perimenopause or menopause clinically in otherwise healthy people aged 45 or older rather than routinely using hormone tests. It does not mean laboratory investigation is never appropriate: younger or atypical presentations and possible alternative causes require different consideration.
Palacios, S., Martin, J., Hernandez, I., & Orozco, R. (2026). Estradiol loss, the “estrobolome,” and midlife symptoms: What the gut microbiome adds to menopause care. Menopause. Advance online publication. https://doi.org/10.1097/GME.0000000000002814
Why it matters: A current narrative review supporting the distinction made in this article: microbiome–oestrogen interactions are biologically plausible and scientifically interesting, but much of the human evidence remains observational and important causal and therapeutic questions remain unresolved. Mechanism should not automatically become a test or treatment claim.
Peters, B., Schwarz, J., Schuppelius, B., Ottawa, A., Koppold, D. A., Weber, D., Steckhan, N., Mai, K., Grune, T., Pfeiffer, A. F. H., Michalsen, A., Kramer, A., & Pivovarova-Ramich, O. (2025). Intended isocaloric time-restricted eating shifts circadian clocks but does not improve cardiometabolic health in women with overweight. Science Translational Medicine, 17(822), eadv6787. https://doi.org/10.1126/scitranslmed.adv6787
Why it matters: An unusually useful study for the fasting discussion because food timing was manipulated while researchers attempted to hold energy intake constant. In 31 women, 26 postmenopausal, early and late eight-hour eating windows shifted circadian timing but did not improve the measured cardiometabolic outcomes. It supports scientific interest in meal timing without justifying a universal menopause fasting prescription.
Rodríguez, M. Á., Quintana-Cepedal, M., Cheval, B., Thøgersen-Ntoumani, C., Crespo, I., & Olmedillas, H. (2026). Effect of exercise snacks on fitness and cardiometabolic health in physically inactive individuals: Systematic review and meta-analysis. British Journal of Sports Medicine, 60(2), 133–141. https://doi.org/10.1136/bjsports-2025-110027
Why it matters: This is useful partly because of what it didn't find. Exercise snacks improved cardiorespiratory fitness and showed some evidence for muscular endurance, with high adherence, but did not significantly improve lower-limb strength, body composition or the cardiometabolic markers examined. That makes it a good reference for feasibility — not a reason to oversell exercise snacks as resistance training.
Singh, P., Beyl, R. A., Stephens, J. M., Noland, R. C., Richard, A. J., Boudreau, A., Hebert, R. C., Ravussin, E., Broussard, J. L., St-Onge, M.-P., & Marlatt, K. L. (2023). Effect of sleep restriction on insulin sensitivity and energy metabolism in postmenopausal women: A randomized crossover trial. Obesity, 31(5), 1204–1215. https://doi.org/10.1002/oby.23739
Why it matters: Particularly relevant because the experiment was conducted specifically in postmenopausal women. Fourteen completed the sleep conditions and nine were analysed. Four nights of sleep restriction reduced insulin sensitivity, measured by the gold-standard clamp technique. Its small size and short duration mean it supports biological plausibility, not a claim about what chronic menopause-related sleep disturbance inevitably does.
Wood, K., McCarthy, S., Pitt, H., Randle, M., Arnot, G., & Thomas, S. (2025). “It's all about the money.” Australian women's perspectives about menopause and the commercial determinants of health. Health Promotion International, 40(5), daaf168. https://doi.org/10.1093/heapro/daaf168
Why it matters: This Australian online survey of 509 women provides the reader perspective behind the opening. Participants expressed concern about commercial actors catastrophising menopause and capitalising on concerns about ageing, while the study also helps explain why accessible commercial propositions may appeal when women are looking for answers.
Zuraikat, F. M., Laferrère, B., Cheng, B., Scaccia, S. E., Cui, Z., Aggarwal, B., Jelic, S., & St-Onge, M.-P. (2024). Chronic insufficient sleep in women impairs insulin sensitivity independent of adiposity changes: Results of a randomized trial. Diabetes Care, 47(1), 117–125. https://doi.org/10.2337/dc23-1156
Why it matters: Provides a longer experimental complement to the small Singh study. Six weeks of mild sleep restriction — about an hour and a half a night less — increased fasting insulin resistance in 38 women, with a larger effect among the postmenopausal participants, and this was not explained by changes in body fat. The significant findings were fasting measures rather than measures taken after a glucose drink, so it is a complement to the Singh clamp study rather than a direct replication of it. It strengthens the case for treating insufficient sleep as part of metabolic assessment without turning sleep disturbance into another simplistic menopause cause-and-effect claim.